VIVASC THERAPEUTICS
Vivasc Therapeutics is a drug development company. They offer services that include drug development, cardiology, atrial fibrillation, and AFiB.
VIVASC THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.vivasctherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
284 K USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Asofarma
Asofarma is a pharmaceutical company that specializes in the development, production, and marketing of products for human use.
Pharmarket
Pharmarket is startup Health Tech that connects buyers and providers of the pharma field.
Current Employees Featured
Investors List
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute investment in Grant - Vivasc Therapeutics
Official Site Inspections
http://www.vivasctherapeutics.com
- Host name: 36.0.153.160.host.secureserver.net
- IP address: 160.153.0.36
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Vivasc Therapeutics"
Vivasc Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Vivasc Therapeutics is a drug development company. They offer services that include drug development, …See details»
Team - Vivasc Therapeutics
Charles (Chip) Dougherty is the Chief Executive Officer of Vivasc Therapeutics. With over 30 years in the life sciences industry and over 20 as an intellectual property attorney advising the …See details»
Vivasc Therapeutics Company Profile 2024: Valuation, Funding ...
Vivasc Therapeutics General Information Description. Developer of a medicinal drug platform designed to treat cardiac problems. The company's platform develops pre-clinical cardiac …See details»
Vivasc Therapeutics Profile and History - Datanyze
Www.vivasctherapeutics.com Vivasc Therapeutics Profile and History Located in Pittsburgh, PA, Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company.See details»
Vivasc Therapeutics - LinkedIn
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various …See details»
Vivasc Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vivasc Therapeutics Inc. of Pittsburgh, PA. Get the latest business insights from Dun & Bradstreet.See details»
VIVASC THERAPEUTICS INC. - Drug pipelines, Patents, Clinical …
Explore VIVASC THERAPEUTICS INC. with its drug pipeline, therapeutic area, technology platform, 1 literature, Technology Platform:miRNA, Drug:CTP-miRNA, CTP-Amio.See details»
Vivasc Therapeutics - Craft
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. It utilizes a proprietary Cardiac Targeting Peptide (CTP) platform technology.See details»
Vivasc Therapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Nov 14, 2023 Explore Vivasc Therapeutics with its drug pipeline, therapeutic area, technology platform, , Technology Platform:miRNA, Small molecule drug, Drug:CTP-miRNA, CTP-Amio.See details»
Vivasc Therapeutics Overview | SignalHire Company Profile
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various …See details»
Vivasc Therapeutics: Contact Details and Business Profile
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various …See details»
Vivasc Therapeutics - Overview, News & Similar companies
Www.vivasctherapeutics.com. Revenue $8.4 Million. Industry Manufacturing General Manufacturing . Recent News & Media. Vivasc Therapeutics Inc. Receives Its Second NIH …See details»
Vivasc Therapeutics, Inc. | Life Sciences PA - Default Site
Www.vivasctherapeutics.com; About. Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) …See details»
Vivasc Therapeutics Inc. - Office of Innovation and Entrepreneurship
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various …See details»
Science - Vivasc Therapeutics
Vivasc Therapeutics is built upon the proprietary Cardiac Targeting Peptide (CTP) platform technology. CTP is a synthetic, non-naturally occurring peptide that acts as a novel vector to …See details»
Vivasc Therapeutics - Company Profile - Tracxn
Sep 13, 2024 Vivasc Therapeutics - Developer of drugs for cardiac treatments. Founded by Chip Dougherty and Matthew Captline in the year 2019. Vivasc Therapeutics has 297 competitors.See details»
Vivasc Therapeutics Inc. in Pittsburgh, PA - (412) 841-2637 - Profile
Vivasc Therapeutics Inc. is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Vivasc Therapeutics Inc. Receives Its Second NIH Phase I STTR …
Oct 19, 2022 PITTSBURGH--(BUSINESS WIRE)--Vivasc Therapeutics Inc. is pleased to announce it has initiated its second NIH Phase I STTR research grant (Award Number …See details»
Vivasc Therapeutics Inc. Receives NIH Phase I STTR ... - Business Wire
Jul 15, 2020 Matthew Captline, Executive Vice President of Operations Phone: +1-412-818-9908 Email: [email protected]. Site Navigation. Home. Home; Submit a Press …See details»
Humacyte's Symvess approved by FDA for vascular injuries
5 days ago Humacyte will now transition to a commercial organization. The company has built a sales team to prepare for the commercial launch of Symvess, which is produced at the …See details»